Measles vaccine vials seized from Hyderabad facility
April 25th, 2008 - 10:26 pm ICT by admin - Send to a friend:
Hyderabad, April 25 (IANS) Authorities Friday seized vials of anti-measles vaccine from Human Biologicals Institute (HBI) here, after the vaccine claimed lives of four children in Tamil Naidu. State drug control administration director general R. P. Meena collected samples from HBI, a subsidiary of Indian Immunologicals Limited (IIL), which in turn is a owned by public sector National Dairy Development Board (NDDB). The drugs manufactured by IIL are said to be responsible for deaths of the four infants in Tamil Nadu Wednesday.
Officials of drug control administration conducted searches at the HBI facility at Gacchibowli and seized 11,000 vials.
Though the central government has stopped the use of anti-measles vaccines manufactured by the company and ordered a probe, the HBI officials maintained that the vaccines supplied to Tamil Nadu were certified by the Central Research Institute (CRI) of Kasauli in Himachal Pradesh.
They, however, have not ruled out contamination due to the procuring authorities not taking the precautionary measures as prescribed.
The contamination could have taken place during the handling or storage as the vaccines have to be kept at temperatures ranging between two and eight degree centigrade till they are administered.
“If the cold-chain breaks the chances of contamination increases,” said IIL’s human vaccine division general manager Dinar Kumar.
The centre has already sent the samples of the vaccine to CRI, Kasauli, and the HBI officials here were awaiting the results.
Dinar Kumar told reporters that nobody from Tamil Nadu government has contacted them.
He claimed that their facilities met the WHO standards and the vaccines produced by it are sent to CRI for testing before being released to any governmental agency. Other states also received the vaccine produced by them through the central government.
IIL, which has been manufacturing veterinary vaccines since 1982, was granted permission by the central authorities in April last year to manufacture measles vaccine.
It was in late 1990s that the company had entered into human vaccination production by setting up human rabies vaccine centre at Ooty (in Tamil Nadu). It has been supplying anti-rabies vaccines to the Tamil Nadu government for last six years.
Related Stories
- Government stops measles vaccine use after four deaths - April 24, 2008
- Another infant succumbs to measles vaccine allergy - April 29, 2008
- New Delhi team investigates measles’ vaccine deaths - April 25, 2008
- Tamil Nadu vaccine victims’ parents to be compensated - April 25, 2008
- Three infants die after small pox vaccination - April 23, 2008
- Kasauli’s Central Research Institute to be restructured - June 4, 2008
- Ramadoss defends decision to close vaccine production units - May 17, 2008
- Researchers close to developing vaccine for encephalitis - May 22, 2008
- AIDS vaccine may never be possibility, say leading scientists - April 24, 2008
- Bharat Biotech sells over 150 mn Hepatitis B vaccines - October 30, 2008
- CPI-M opposes closure of vaccine units - May 30, 2008
- Suspected botched vaccination claims four infants in Assam - October 22, 2008
- NHRC issues notice to Tamil Nadu Government on student violence - November 14, 2008
- HIV vaccine fails to give promising results - November 13, 2008
- DNA-based vaccine against West Nile virus on the anvil - November 4, 2008
- administration director
- anti measles vaccine
- biologicals
- central government
- cold chain
- contamination
- control administration
- cri
- dairy development
- degree centigrade
- governmental agency
- himachal
- human vaccine
- indian immunologicals
- kasauli
- national dairy development board
- precautionary measures
- tamil nadu
- vaccine division
- veterinary vaccines
Posted in Health Science, |

